Navigation Links
HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
Date:2/25/2008

third quarter.

-- Based on our current complement of hospitals and outpatient satellites,

we expect our 2008 consolidated net operating revenues to be in the

range of $1.80 billion to $1.85 billion.

-- Adjusted consolidated EBITDA is expected to be in the range of $320

million to $335 million.

Included in this projected 2008 adjusted consolidated EBITDA range is approximately $8 million of professional fees with a consulting firm associated with our TeamWorks initiative. TeamWorks is an operational initiative designed to identify best practices in a number of key areas and standardize those practices across all our hospitals. This expense will be included in our calculation of adjusted consolidated EBITDA in 2008 and is not expected to recur in 2009.

We expect our diluted loss per share available to common shareholders will be in the range of ($0.08) to $0.00 per share. However, there are two non- routine items included in this "as reported" range estimate.
-- In accordance with Financial Accounting Standards Board Statement

No. 144, Accounting for the Impairment or Disposal of Long-Lived

Assets, we will accelerate the depreciation of our corporate campus so

that the net book value of the corporate campus equals the estimated

net proceeds expected to be received on the sale transaction's closing

date. The year-over-year impact of this acceleration of depreciation

approximates $10 million. No similar charges are expected in 2009.

-- During 2008, we expect to incur approximately $25 million of

professional fees including legal fees related to our derivative

litigation and professional fees related to income tax consulting fees

and various projects surrounding our pursuit of our remaining income

tax refund claims. While no assurances can be provided that similar

costs will not be incurred in 2009, any am
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Issues Statement on Medicare Bill and 75% Rule
3. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Date of Third Quarter Earnings Conference Call
6. HealthSouth Corporation Appoints New Member to Board of Directors
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. NHP Reports Fourth Quarter and Full Year 2007 Earnings
9. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
10. Clarity for Consumers on Botox Complication and Death Reports
11. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... The Hydration ... allopathic medicine, opens its second location this week at 31542 S. Coast Hwy, ... feet of lounge space for patients to relax while receiving safe and effective ...
(Date:9/2/2015)... Burnsville, MN (PRWEB) , ... September 02, 2015 , ... ... forward to it; others dread it. However, few are prepared to face the academic ... once school starts. Our schools haven’t prepared them since schools don’t teach students how ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... the upper extremity surgical market, announced today that more than 600 successful patient ... in the hand. Plus, nearly 70 of these procedures have been on ...
(Date:9/2/2015)... ... September 02, 2015 , ... Lakeview Health, a nationally recognized ... Overdose Awareness Day. The goal is to provide people information regarding drugs and ... they may get help. , Lakeview Health will be publishing information ...
(Date:9/2/2015)... PA (PRWEB) , ... September 02, 2015 , ... Pentec ... prestigious 2015 Inc. 5000 List for an impressive sixth consecutive year. Less than 5 ... with only twelve firms in the “health” sector. Pentec’s 3-year revenue growth rate ...
Breaking Medicine News(10 mins):Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2
... Tenn., Jan. 13 The National Eczema Association,(NEA) awarded ... Lotion. , The NEA Seal ... Education (EASE) program, which is intended to improve the,quality ... eczema and sensitive,skin. , "These ...
... now open for a more rewarding challenge , ... Jenkintown, PA (PRWEB) January 13, 2009 ... resolutions and according to USA.gov, losing weight and getting fit are among the ... many of those eager to fulfill their vows is to lace up their ...
... to meet their customers, product needs quickly and efficiently, Nationwide Medical/Surgical ... 2009-2010 season beginning in August. , ... (Vocus) January ... the Flu Vaccine for the 2009-2010 flu season. ...
... persistence to seek out the best treatment options available ... leg today. Bill,s proactive efforts led him to revolutionary ... Methodist Hospital, in Columbus, Ohio, where a team of ... During the minimally invasive procedure, they also found and ...
... announces the launch of their new website www.GlaceComplete.com . ... to Glenwood Systems and the company,s turbo-charged practice management/billing system GlaceComplete ... information. , ... Waterbury, CT (PRWEB) January Monday 12, ...
... of the 21,000 Americans who die each year of ... likely cause. So, the American Association of ... Cancer Survivors Against Radon (CanSAR) with a ... those who never smoked. Those making the connection, along ...
Cached Medicine News:Health News:National Eczema Association Anoints Theraplex Child-Friendly Eczema Products with Seal of Acceptance 2Health News:The Breast Cancer 3-Day Challenges Americans to Get Out of the New Year's Resolution Rut 2Health News:The Breast Cancer 3-Day Challenges Americans to Get Out of the New Year's Resolution Rut 3Health News:The Breast Cancer 3-Day Challenges Americans to Get Out of the New Year's Resolution Rut 4Health News:Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine 2Health News:Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio 2Health News:Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio 3Health News:Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio 4Health News:Glenwood Systems, LLC Launches New Website -- GlaceComplete.com 2Health News:Program to Identify Likely Victims of Radon-Related Lung Cancer; Survivors Commit to Risk Reduction Despite Failed Government Policy 2Health News:Program to Identify Likely Victims of Radon-Related Lung Cancer; Survivors Commit to Risk Reduction Despite Failed Government Policy 3Health News:Program to Identify Likely Victims of Radon-Related Lung Cancer; Survivors Commit to Risk Reduction Despite Failed Government Policy 4
(Date:9/2/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... of new cancer therapies, today announced that it ... of the Mechanisms and Cytotoxic Activity of Dianhydrogalactitol ... Wild-type and Mutant p53," at the American ...
(Date:9/2/2015)... Sept. 2, 2015 CytoSorbents Corporation (NASDAQ: ... CytoSorb ® blood purification technology to reduce deadly ... that CEO Dr. Phillip Chan , MD, PhD, ... Investment Conference (sponsored by H.C. Wainwright & ... New York City.  Currently, the management ...
(Date:9/2/2015)... Ascletis announced today the completion of a US$35 million ... C-Bridge Capital, joined by Tasly Pharmaceutical and ... Company before financing was US$300 million. The ... Ascletis, pipeline, strengthen global development capabilities and enhance GMP ... investors, Ascletis is now entering an exciting new era. ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 2CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 3CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 4Ascletis Secures US$35 Million Financing 2Ascletis Secures US$35 Million Financing 3
... VIENNA, Va., June 20, 2007 /PRNewswire/ ... announced the successful completion of,pharmacokinetic and ... hormone, long-acting interferon beta and,long-acting erythropoietin. ... demonstrated superb durability of the long-acting,proteins, ...
... /PRNewswire-FirstCall/ -- Amylin,Pharmaceuticals, Inc. today announced that ... injection and,SYMLIN(R) (pramlintide acetate) injection, and its ... Diabetes Association's,(ADA) 67th Annual Scientific Sessions being ... 26. The company will also host an ...
Cached Medicine Technology:Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 2Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 3Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 4Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4
... protein 4 (IGFBP-4) is a 24 kDa protein ... IGF-I and IGF-II. It is also present in ... 28 kDa. IGFBP-4 has been identified in all ... types, including fibroblasts, neuroblastoma, prostate and bone cells ...
... the adrenal gland and gonads, is the ... both of which may be subsequently converted ... activity, estimated at ~(less than or equal ... androstenedione levels often exceed testosterone in both ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
... a 7.5 kDa peptide which is secreted primarily ... mitogenic and metabolic actions involved in cellular growth. ... to target cell receptors. IGF-II binds with high ... monomeric protein which also serves as the receptor ...
Medicine Products: